The genetic landscape of CM is characterized by several key mutations. BRAF mutations are observed in approximately one-third of CM patients, with the most common mutation being V600E, accounting for approximately 80% of BRAF mutations [35]. This evidence concerns the gene BRAF and cutaneous mastocytosis.